Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Katsunori Iwasaki"'
Autor:
Hiroshi Moriyama, Yoshio Tsuboi, Mosaburo Kainuma, Kaori Kubota, Takuya Watanabe, Katsunori Iwasaki, Shutaro Katsurabayashi, Masaki Nagao, Kotaro Takasaki, Takayasu Mishima
Publikováno v:
Traditional & Kampo Medicine. 4:51-54
Aim Alzheimer's disease (AD) is a chronic neurodegenerative condition most often found in older people. Cerebrovascular disease is commonly found in patients with AD. Hachimijiogan (HJG) is a herbal medicine commonly used to treat age-related disease
Autor:
Masaki Nagao, Toshitsugu Miyazaki, Naoki Imagawa, Satoshi Yamano, Takuya Watanabe, Kaori Kubota, Hisatomi Ito, Kentaro Igami, Katsunori Iwasaki, Shutaro Katsurabayashi
Publikováno v:
Traditional & Kampo Medicine.
Autor:
Masaki Nagao, Shutaro Katsurabayashi, Marika Hiarata, Kaori Kubota, Soichiro Tsutsumi, Akinobu Hatae, Takuya Watanabe, Kazuma Matsui, Hiroya Omori, Kazuma Mine, Katsunori Iwasaki
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:3-Y
Autor:
Kotaro Takasaki, Izzettin Hatip-Al-Khatib, Kaori Kubota, Katsunori Iwasaki, Funda F. Bölükbaşı Hatip, Risako Fujikawa, Ai Nogami-Hara, Nobuaki Egashira, Shutaro Katsurabayashi, Takuya Watanabe, Masaki Nagao
Ethnopharmacological relevance Japanese Angelica acutiloba root (Angelica root) is included in several Kampo medicines including Yokukansan (YKS). Angelica root and YKS are used for the treatment of a variety of psychological and neurodegenerative di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3771c8d5ca96911db18dd35a2c655c05
https://doi.org/10.1016/j.jep.2017.12.025
https://doi.org/10.1016/j.jep.2017.12.025
Autor:
Ryoji Nishimura, Yuko Hirai, Ai Nogami, Naoki Uchida, Kenichi Mishima, Shutaro Katsurabayashi, Hiroshi Moriyama, Kotaro Takasaki, Masaki Nagao, Kaori Kubota, Katsunori Iwasaki
Publikováno v:
Traditional & Kampo Medicine. 1:19-26
Aim: Symptoms of dementia are classified into cognitive dysfunction and behavioral and psychological symptoms of dementia, including sleep disturbance. Yokukansan (YKS) is effective for sleep disturbance in patients with dementia, but the mechanisms
Publikováno v:
Neuroscience Letters. 536:74-79
Epidemiological studies suggest that cerebral ischemia may contribute to the onset and progression of Alzheimer's disease (AD). However, the mechanism by which ischemic events trigger the onset and progression of AD is poorly understood. Acetylcholin
Autor:
Yusuke Gotoh, Ichiro Horie, Nobuaki Egashira, Toshio Matsuda, Kazuhide Hayakawa, Masamitsu Shimazawa, Kazuhiro Tsuruma, Hideaki Hara, Kenichi Mishima, Kyoji Horie, Michihiro Fujiwara, Takahiro Iwamoto, Issei Komuro, Takuya Iyoda, Hiroko Namimatsu, Satomi Kita, Katsunori Iwasaki, Junji Takeda, Nobutaka Morimoto, Akemichi Baba
Publikováno v:
Biochemical and Biophysical Research Communications. 429:186-190
The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear
Autor:
Ryoji Nishimura, Naoki Uchida, Kotaro Takasaki, Kanako Uchida, Shutaro Katsurabayashi, Keiichi Irie, Kaori Kubota, Katsunori Iwasaki, Kenichi Mishima, Michihiro Fujiwara, Taro Shindo, Rika Onimura
Publikováno v:
Biological and Pharmaceutical Bulletin. 35:2141-2147
Telmisartan, an angiotensin type 1 receptor blocker, is used in the management of hypertension to control blood pressure. In addition, telmisartan has a partial agonistic effect on peroxisome proliferator activated receptor γ (PPARγ). Recently, the
Autor:
Ai Nogami, Kaori Kubota, Kazuya Nakamura, Masahiko Morita, Chihiro Kawasaki, Katsunori Iwasaki, Koji Morishita, Risako Fujikawa, Kenichi Mishima, Kazuko Yamaguchi, Shutaro Katsurabayashi, Kotaro Takasaki, Kanako Uchida, Michihiro Fujiwara
Publikováno v:
Journal of Pharmacological Sciences, Vol 116, Iss 3, Pp 232-237 (2011)
Citidine-5-diphosphocholine or citicoline (CDP-choline) is used as a neuroprotective and memory-enhancing drug in cerebral stroke, Alzheimer’s disease, and other neurovascular diseases. Non-clinical studies have demonstrated the neuroprotective eff
Autor:
Ryozo Oishi, Kenichi Mishima, Nobuaki Egashira, Fengling Pu, Makiko Enoki, Yasuo Sei, Tomohiro Kaneko, Michihiro Fujiwara, Keiichi Irie, Takuya Okamoto, Katsunori Iwasaki, Hidetoshi Kamimura
Publikováno v:
Journal of Natural Medicines. 64:167-174
We previously reported that 21-day (14-day pre-ischemic and 7-day post-ischemic) treatment with Kangen-karyu (KGKR) improved spatial memory impairment and hippocampal neuronal death induced by repeated cerebral ischemia (2 x 10-min, 1-h interval) in